menu search

HOOKIPA Pharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights

HOOKIPA Pharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights
HOOKIPA reported positive preliminary Phase 2 data on HB-200 in combination with pembrolizumab in 1st-line setting for advanced head and neck cancer Recruitment ongoing for two Phase 1 clinical trials (HB-300 for advanced prostate cancer and Gilead-partnered HB-400 for chronic hepatitis B) IND-enabling activities in progress to advance two additional therapeutics into the clinic in […] The post HOOKIPA Pharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights appeared f... Read More
Posted: Aug 10 2023, 11:01
Author Name: forextv
Views: 092062

Search within

Pages Search Results: